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Abstract
The identification of protein kinase targets remains a significant bottleneck for our understanding of signal transduction in
normal and diseased cellular states. Kinases recognize their substrates in part through sequence motifs on substrate
proteins, which, to date, have most effectively been elucidated using combinatorial peptide library approaches. Here, we
present and demonstrate the ProPeL method for easy and accurate discovery of kinase specificity motifs through the use of
native bacterial proteomes that serve as in vivo libraries for thousands of simultaneous phosphorylation reactions. Using
recombinant kinases expressed in E. coli followed by mass spectrometry, the approach accurately recapitulated the well-
established motif preferences of human basophilic (Protein Kinase A) and acidophilic (Casein Kinase II) kinases. These motifs,
derived for PKA and CK II using only bacterial sequence data, were then further validated by utilizing them in conjunction
with the scan-x software program to computationally predict known human phosphorylation sites with high confidence.
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Introduction
Protein phosphorylation provides one of the primary means of
transducing cellular signals, and as such has been utilized by a
majority of organisms that span all domains of life [1]. Extensive
research has been carried out to uncover the existence and specific
location of phosphorylation sites on proteins as a means of
understanding protein function and regulation. Although advances
in enrichment and detection technologies have led to an
exponential increase in known phosphorylation sites on substrate
proteins over the past decade [2], an important limitation of these
strategies is that they do not provide information on the kinases
responsible for the phosphorylation events. The absence of kinase-
specific information thus greatly limits our ability to understand
the role of individual kinases within dynamic signal transduction
networks.
Many variables contribute to the likelihood of a kinase targeting
a given protein in the cell including i) temporal expression of the
kinase and substrate, ii) subcellular localization of the kinase and
substrate, iii) physical interactions between the kinase, substrate
and often other proteins, and iv) the existence of sequence
specificity determinants (also known as motifs) on the substrate
protein. Given that kinase specificity motifs can vary widely
(compare, for example, the RxRxxS sequence preference of Akt
kinase [3] to the YMxM sequence preference of the Insulin
Receptor kinase [4]), it is not surprising that they have served as a
major means of generating hypotheses regarding kinase/substrate
pairs that can then be experimentally verified. Thus, kinase
specificity motifs have been of significant importance in elucidat-
ing kinase function and cellular signaling mechanisms.
To date, the most established and widely used methods for
kinase specificity determination have involved incubation of
purified recombinant kinase with combinatorial peptide libraries
in vitro [5,6]. Depending on the format of the reaction (i.e., in
solution or on streptavidin-coated membranes), read-out of the
specificity is accomplished by either Edman degradation or
autoradiography. At present, it is not practical to use tandem
mass spectrometry in conjunction with combinatorial peptide
library methods because, among other reasons, it would require de
novo peptide sequencing by mass spectrometry, which is currently
challenging. Although they have provided valuable data for many
kinases, combinatorial peptide library based methods share several
limitations (Table 1).
Most recently, several groups have expanded upon an approach
first presented by Huang et al. in 2007 [7] to use phosphatase
treated intact proteins from eukaryotic cellular lysate as a
‘‘proteome-derived’’ peptide library for subsequent in vitro kinase
reactions. This approach has been used to both query for potential
kinase substrates in vitro and to derive kinase motifs [8,9,10]. While
these methods have the substantial advantage of being able to use
tandem mass spectrometry as a peptide readout, they suffer from
the need for large amounts of purified active recombinant kinase,
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phosphoproteins, and the assessment of phosphorylation under
often unfavorable in vitro conditions.
Here we address the aforementioned deficiencies of both the
combinatorial and ‘‘proteome-based’’ approaches to kinase
specificity motif determination by presenting a novel and simple
strategy that we call ProPeL (which stands for Proteomic Peptide
Library). Importantly, the ProPeL methodology represents the first
use of a live bacterium (here, E. coli) acting as an in vivo peptide
library for thousands of simultaneous phosphorylation reactions
carried out by an exogenous kinase.
Briefly, a kinase of interest is cloned and expressed in E. coli
using standard techniques. Following induction, the active kinase
(which uses cellular ATP as a cofactor) can phosphorylate the
native E. coli proteome in a manner that is consistent with the
sequence specificity of the kinase. Typically, such modifications to
the host proteome would go unmeasured, however, in our
approach they serve as a convenient readout of the kinase motif.
In order to detect these phosphorylation sites, the bacteria are
lysed, proteins are digested using trypsin, phosphopeptides are
enriched using SCX/IMAC [11], and the resulting phosphopep-
tides are sequenced by tandem mass spectrometry. Despite the fact
that the differentially phosphorylated E. coli peptides are not
natural substrates for the expressed kinase, phosphorylation motifs
are statistically identified using the motif-x [12] and pLogo [13]
software with E. coli selected as a background database to account
for the proteomic environment within which the reaction occurs.
Importantly, the ProPeL strategy is made possible by the fact
that E. coli, i) lacks any eukaryotic-like serine/threonine kinases, ii)
has only two kinases with known serine/threonine activity, and iii)
has very low levels of endogenous serine and threonine phosphor-
ylation [14]. A comparison of the different methods for
determining kinase specificity is provided in Table 1.
Results
As a proof of principle, we applied the ProPeL approach to two
human kinases, Protein Kinase A (PKA) and Casein Kinase II
(CK II), both of which have well-defined motifs [6,15]. In total, the
methodology resulted in the detection of 806 phosphorylation sites
in E. coli expressing PKA, and 467 phosphorylation sites in E. coli
expressing CK II. By comparison, negative controls (untrans-
formed E. coli and E. coli expressing empty plasmid) led to the
identification of only 23 endogenous phosphorylation sites,
consistent with the known low background phosphorylation levels
in E. coli [14] (see Table S1). Following removal of known
endogenous phosphorylation sites obtained from both negative
controls in the present study and an additional study of E. coli
phosphorylation [14], 794 PKA phosphorylation sites and 458 CK
II phosphorylation sites remained, which served as the data sets for
motif analyses.
In both cases, the motif determined using the ProPeL
methodology mirrored the established kinase consensus sequences
(Figure 1A–D). Specifically, the most prominent previously
characterized specificity determinants of PKA – a preference for
basic residues upstream of the modification site at the 22 and 23
positions as well as a hydrophobic residue preference at the +1
position [6] – were clearly evident in the serine- and threonine-
centered pLogos for PKA (Figures 1A and 1B respectively).
Similarly, the most critical specificity determinants of CK II
phosphorylation – a preference for acidic residues upstream and
downstream of the phosphorylation site, with the +1 and +3
positions being most important [15] – were also clearly evident in
the serine- and threonine-centered pLogos for CK II (Figures 1C
and 1D respectively). It should be noted that the y-axes of the
pLogos shown in Figure 1 are on a logarithmic scale. Thus, for
example, while the R at the 23 position in Figure 1A has an
Table 1. Comparison of combinatorial peptide library screening, proteome-derived library, and ProPeL motif discovery
methodologies.
Combinatorial peptide library
screening Proteome-derived libraries ProPeL
Need for purified recombinant kinase? Yes Yes No
Use of radioactivity in some assays? Yes No No
Can use tandem MS to determine
sequence?
No Yes Yes
Can accurately determine disfavored
residues at motif positions?
No Yes Yes
Can determine specificity of all residues
at all motif positions?
No* Yes Yes
Motif width limit? Yes (limited by library construction) Dependent on protocol** No
Demonstrated successful
phosphorylation predictions
from resulting motifs?
Yes (Scansite) No Yes (scan-x)
Assessment of kinase specificity under
in vivo conditions?
No No Yes
Up front costs? Higher Lower Lower
Potential for incomplete
dephosphorylation of endogenous
phosphoproteins?
Not applicable Yes Not applicable
Relative number of protocol steps
(i.e., ease of protocol).
Most Fewer Fewest
*Phosphorylatable residues (Ser and Thr) and Cys are not included in combinatorial peptide libraries used for kinase specificity determination.
**In proteome-derived libraries motif width limits depend on whether the kinase reaction is performed before or after proteolytic peptide digestion.
doi:10.1371/journal.pone.0052747.t001
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255, the hydrophobic cluster (I/L/M/V/F)
at the +1 position, albeit smaller, still has a highly significant p-
value of 10
210. Motif deconvolution using the motif-x algorithm
[12] further corroborated the pLogo results, yielding motifs highly
consistent with the known specificities of PKA and CK II (see
Figure 2). By comparison, pLogos for known endogenous E. coli
phosphorylation sites (i.e., 86 sites from our negative controls and
from the Macek et al. study [14]) revealed no statistically
significant residues, and thus no overall motif (Figure 1E and
1F). Finally, comparison of the phosphorylation sites obtained in
the PKA and CK II experiments revealed only negligible overlap
(21 peptides out of over 1200 total peptides), with the majority of
overlapping peptides bearing similarity to both the PKA and CK
II consensus sequences. As such, it is highly unlikely that
expression of PKA and CK II resulted in the activation of native
E. coli kinases.
To quantitatively assess the accuracy of the motifs obtained
through the ProPeL method, we used a previously devised scoring
strategy, the scan-x score [13], that utilizes the raw pLogo position
weight matrix values to measure the goodness-of-fit between a
pLogo and a particular sequence of interest (see Figure 3). Scoring
320 known human PKA substrates retrieved from the Phospho-
SitePlus [16] database with the PKA pLogo obtained using the
ProPeL method, and an equivalent number of random phosphor-
ylatable residues from the human proteome with the same PKA
pLogo, yielded a highly statistically significant difference in
average scan-x score (61.5 versus 5.1, Mann-Whitney
U=94323.0, n=320, p,10
275). Similarly, scoring 348 known
human CK II substrates with the CK II pLogo, and an equivalent
number of random human phosphorylatable residues with the
same CK II pLogo, also yielded a highly statistically significant
difference in average scan-x score (41.1 versus 1.5, Mann-Whitney
U=104230.5, n=348, p,10
260). These results both demonstrate
Figure 1. pLogo representations of substrate sequence specificities. pLogos for Protein Kinase A (A, B), Casein Kinase II (C, D), and control (E,
F) illustrate preferred residues by position. Note, pLogos are derived from phosphorylation sites in E. coli obtained using the ProPeL methodology
(after subtraction of endogenous phosphorylation sites). In each pLogo, residue heights are proportional to their log binomial probabilities in the
context of the E. coli background with residues above the x-axis indicating overrepresentation and residues below the x-axis indicating
underrepresentation. The central residue in each pLogo is fixed and denotes the modification site. The pLogos and corresponding extracted motifs
(see Figure 2) are highly consistent with the known basophilic specificity of PKA and acidophilic specificity of CK II. Additionally, the control
phosphorylation sites (i.e., endogenous E. coli phosphorylation sites) do not conform to a motif and lack any statistically significant residues.
doi:10.1371/journal.pone.0052747.g001
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to accurately discern the difference between a random serine or
threonine residue and a true PKA or CK II phosphorylation site,
and in turn that the pLogos are a strong representation of known
PKA and CK II specificities.
We then used scan-x to identify potential PKA and CK II native
kinase targets in the human proteome using these same pLogos
(Tables 2 and 3). In the case of PKA, the top 100 predicted
phosphorylation sites (out of nearly 1.17 million potentially
phosphorylatable unique serine- and threonine-centered 15 mers
in the human proteome) contained two sites (on proteins KCNH2
and SOX9) known to be phosphorylated by PKA (data not shown,
hypergeometric p-value ,10
23). Within just the top 20 predictions
(Table 2), eight sites were previously verified to be phosphorylated
(by an unknown kinase) in vivo (hypergeometric p-value ,10
25),
and 4 proteins had associations with PKA either directly or
through protein family members. In the case of CK II (Table 3),
the 3
rd highest scoring site in the entire human proteome is, in fact,
a known CK II substrate (MCM2, Ser139, scan-x score=118.1). In
addition, the highest scoring candidate CK II substrate in the
human proteome (NADAP, Ser312, scan-x score=123.2) has also
been shown to be phosphorylated at our predicted site (Ser 312) by
27 independent tandem mass spectrometry studies [16], and was
most recently shown to interact with CK II [17] suggesting that it
is a likely CK II substrate. Overall, of the top 20 CK II
predictions, 30% (6/20) of sites are already known to be
phosphorylated by CK II at the precise predicted site, and 70%
(14/20) have known, experimentally verified CK II interactions.
Note, that the probability of selecting even a single known CK II
phosphorylation site by chance is extremely low ,348/1,170,000
(or 0.03%), thus finding 6 out of 20 known CK II sites has a
hypergeometric p-value of ,10
217. Given the limited present
knowledge of the phosphorylation state of proteins, it is also
striking that 80% (16/20) of the top 20 predicted CK II
phosphorylation sites were previously shown to be phosphorylated
(hypergeometric p-value ,10
213); most, in dozens of independent
experiments. The remaining 4 of the top 20 predicted CK II
phosphorylation sites had no prior experimental evidence of
phosphorylation. However, these 4 predictions are all contained
within tryptic peptides that are longer than 35 amino acids, and
Figure 2. motif-x analyses for PKA (A and B) and CK II (C and D). These motif extraction results illustrate the inter-residue correlations found
among the phosphorylated peptides identified using the ProPeL methodology, and are highly consistent with the previously established consensus
sequences for the PKA and CK II kinases.
doi:10.1371/journal.pone.0052747.g002
Figure 3. Goodness-of-fit of the pLogos derived from ProPeL and actual known kinase substrates versus random substrates.
Average pLogo position weight matrix scores of CK II (red) and PKA (blue) pLogos when scanned against known human substrates from the
PhosphoSitePlus database compared to average scores obtained from scanning CK II and PKA pLogos against an equivalent number of random
human serine and threonine residues. Error bars represent 95% confidence intervals.
doi:10.1371/journal.pone.0052747.g003
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throughput tandem mass spectrometry workflows.
The aforementioned results demonstrate that the motifs
obtained via the ProPeL methodology can be used to scan whole
proteomes in order to predict new high-confidence phosphoryla-
tion sites specific to a given kinase. Therefore, in addition to
uncovering the motifs for kinases with unknown sequence
specificities, by using a bacterial expression system, the ProPeL
methodology can be used in conjunction with scan-x as an efficient
tool to predict kinase substrates within their native proteomes.
Finally, to assess the tradeoff between the sensitivity and
specificity of ProPeL-based scan-x predictions, and to compare
these results to those obtained using the combinatorial peptide
library based Scansite predictor [18], we generated ‘‘gold-
standard’’ positive and negative kinase data sets for PKA and
CK II based on known data contained within the PhosphoSitePlus
database. These data were then used to create receiver operating
characteristic (ROC) curves for both the scan-x and Scansite PKA
and CK II specific predictors (see Figure 4A–D). Aside from
illustrating the strong predictive capacity of the ProPeL/scan-x
methodology, the ROC curves also provide evidence that no
significant predictive biases arise from using bacterially derived
peptide libraries to make eukaryotic predictions and that the
scoring matrices derived from synthetic peptides and bacteria are
virtually interchangeable. It is worth noting that many of the
known substrates in the ‘‘gold-standard’’ that we used were
determined after the release of Scansite in 2003. Inspection of a
subsample of research articles demonstrating PKA and CK II
phosphorylation sites contained within the PhosphoSitePlus
database revealed that a significant number of sites were in fact
experimentally verified as a direct result of performing Scansite
analyses [19,20]. Thus, the Scansite ROC curves in Figures 4A–D
likely represent a slight overestimation of Scansite predictive
capacity.
Discussion
The present study represents the first application of an
exogenous in vivo system being used as a reaction vessel to query
the specificity of a single protein kinase. The success of the
methodology is largely due to the ease of expressing kinases in E.
coli – an organism with a sufficiently large proteome to provide a
complex substrate library and extremely low endogenous phos-
phorylation levels [14]. As such, each phosphorylation event
detected in a ProPeL experiment is likely to be the result of the
expressed exogenous kinase, which is unencumbered by the
background noise of other interfering kinases (Figure 1). Addi-
tionally, motifs discovered with this strategy are the result of
analyzing many substrates to discover a statistically significant
pattern [12]. Thus, the identity of the individual protein targets,
and whether they originate from human or E. coli cells is irrelevant
to the task of determining a motif for the kinase. This premise is
Table 2. Top 20 scan-x PKA phosphorylation predictions based on a human whole proteome scan with the PKA motif obtained
using the ProPeL methodology.
scan-x rank* UniProt ID Site
Known phosphorylation site? (if yes, in how
many experiments has it been reported?**) Known PKA association?
1 KCNH7_HUMAN S896 Yes (7 experiments) No, but family member KCNH2 is
phosphorylated by PKA. [34]
2 FLII_HUMAN S436 Yes (163 experiments) No
3 SEM4G_HUMAN S713 Yes (1 experiment) No
4 CHD8_HUMAN S506 No*** Yes, shown to bind PKA. [35]
5 ADML_HUMAN S153 No*** No
6 H2AFB_HUMAN S10 No*** No
7 KCNK5_HUMAN S266 No No, but family members KCNK2, KCNK3, and
KCNK9 are phosphorylated by PKA. [36,37]
8 ATAD2_HUMAN S379 Yes (6 experiments) No
9 MCLN2_HUMAN S530 No*** No, but family member Mucolipin 1 is
phosphorylated by PKA. [38]
10 FOXD1_HUMAN S58 No*** No
11 RBM34_HUMAN S14 Yes (81 experiments) No
12 PTPRG_HUMAN S55 No No
13 GLTL1_HUMAN S520 No No
14 PHF14_HUMAN S835 Yes (54 experiments) No
15 KIRR1_HUMAN S527 No*** No
16 UBP51_HUMAN S356 Yes (1 experiment) No
17 EI24_HUMAN S46 Yes (49 experiments) No
18 RED2_HUMAN S30 No*** No
19 DYSF_HUMAN S593 No No
20 TRI17_HUMAN S59 No*** No
*Out of 1,168,144 total serine and threonine residues.
**From the PhosphoSitePlus database.
***Tryptic peptide containing the predicted phosphorylation site less than length 10 or greater than length 35.
doi:10.1371/journal.pone.0052747.t002
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construction from E. coli proteins phosphorylated by CK II and
PKA led to the direct prediction of a large number of previously
validated phosphorylation sites and known CK II and PKA
substrates in the human proteome (Tables 2 and 3).
Aside from its simplicity, the ProPeL approach has a number of
other benefits over the well-established combinatorial peptide
library approaches and the recent proteome-derived library
approaches (Table 1). Most significantly, by shifting the kinase
reaction into E. coli, there is an immediate benefit of having the
enzyme perform its function in a more physiologically relevant
biochemical environment, thus allowing kinases as well as their
cognate bacterial substrates to assume structured conformations,
and obviating the need to adjust a variety of experimental
parameters (buffer conditions, ATP concentrations, etc.) or to
purify large quantities of intact and active recombinant kinases.
Additionally, when compared to the most current combinatorial
peptide library approaches [5], there is an economic benefit
because the initial cost of a ProPeL experiment is a fraction of the
cost of combinatorial peptide library synthesis. We anticipate that
this cost advantage will only be magnified as tandem mass
spectrometry core facilities and instrumentation become more
accessible and strategies for phosphopeptide enrichment become
more efficient.
In the present study, large portions of the ProPeL methodology
were carried out independently by two different laboratories (one
lab for each kinase), using slightly varying interpretations of the
SCX/IMAC protocol (see Methods section for details). The fact
that these independent experiments yielded hundreds of phos-
phorylation sites, both of which accurately recapitulated the
expected motifs, provides evidence for the robustness of the
approach. Additionally, the use of acidophilic (Casein Kinase II)
and basophilic (Protein Kinase A) kinases from opposite sides of
the kinase phylogeny suggests a potential for applicability to
intermediate kinases without significant bias from the E. coli
intracellular environment.
While the human proteome is much larger than that of E.
coli, we demonstrate here that the diversity of the E. coli
proteome is more than sufficient for the discovery of protein
kinase motifs, which typically contain no more than two to
Table 3. Top 20 scan-x CK II phosphorylation predictions based on a human whole proteome scan with the CK II motif obtained
using the ProPeL methodology.
scan-x rank* UniProt ID Site
Known phosphorylation site? (if yes, in how
many experiments has it been reported?**) Known CK II association?
1 NADAP_HUMAN S312 Yes (27 experiments) Yes [17]
2 DAXX_HUMAN S443 No*** Yes, CK II phosphorylates at alternate sites.
[39]
3 MCM2_HUMAN S139 Yes (235 experiments) Yes, CK II phosphorylates at predicted site.
[40]
4 RPC7_HUMAN S157 Yes (4 experiments) No
5 BAZ1B_HUMAN S1259 No*** No
6 TFP11_HUMAN S98 Yes (26 experiments) No
7 BMS1_HUMAN S442 No*** Yes [17]
8 ENPL_HUMAN S306 Yes (14 experiments) Yes [41]
9 NUCL_HUMAN S145 Yes (80 experiments) Yes [42]
10 CCD97_HUMAN S257 Yes (3 experiments) No
11 GLRPX_HUMAN S205 Yes (29 experiments) Yes [17]
12 HS90A_HUMAN S231 Yes (45 experiments) Yes, CK II phosphorylates at predicted site.
[43]
13 HS90B_HUMAN S226 Yes (101 experiments) Yes, CK II phosphorylates at predicted site.
[43]
14 CENPB_HUMAN S456 Yes (1 experiment) Yes, CK II phosphorylates at predicted site.
[44]
15 PRPF3_HUMAN S619 Yes (23 experiments) Yes, CK II phosphorylates at alternate site.
[45]
16 CCD94_HUMAN S211 Yes (20 experiments) No
17 MYH9_HUMAN S1943 Yes (764 experiments) Yes, CK II phosphorylates at predicted site.
[46]
18 F123B_HUMAN S928 No*** No
19 SIAL_HUMAN S149 Yes**** (3 experiments) Yes, CK II phosphorylates at predicted site.
[47]
20 TOP2A_HUMAN S1106 Yes (18 experiments) Yes, CK II phosphorylates at alternate sites.
[48,49]
*Out of 1,168,144 total serine and threonine residues.
**From the PhosphoSitePlus database.
***Tryptic peptide containing the predicted phosphorylation site greater than 35 residues in length.
****Phosphorylated at homologous site in rat and cow.
doi:10.1371/journal.pone.0052747.t003
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through motif deconvolution using motif-x we were able to
detect numerous motifs with 3 fixed positions (Figure 2), thus
indicating that the E. coli proteome is large and diverse enough
to detect inter-residue correlations. Nevertheless, it should be
possible to use the ProPeL method with alternate bacterial
expressions systems (such as members of the Bacillus genus) as a
way to interrogate different sequence repertoires available for
motif determination.
It is well established that expressing a variety of exogenous
proteins in E. coli, including kinases, may result in a range of
toxicities to the bacterial host. Because of this, as with other
protein expression systems, some kinases will likely require some
fine-tuning of expression and culture conditions. Additionally,
there exist kinases that require specific ligand binding (calcium/
calmodulin [22], AMP [23], etc.) or phosphorylation events by
upstream kinases for activity [24], and others that require a
priming phosphorylation event for substrate specificity [25]. In
some cases it will be possible to circumvent these issues by
expressing only kinase catalytic domains/subunits, or by co-
expressing the given kinase with its necessary activating (or
priming) enzyme/ligand; however, in some cases the ProPeL
methodology may prove unsuitable. Although we do not expect
the ProPeL methodology to be effective for all kinases, even if
20% of kinases could be effectively expressed in bacteria, this
would represent over one hundred kinases in Homo sapiens alone
whose sequence specificity could be determined rapidly and
accurately. As an alternative, however, we propose here that
one may also use the ProPeL approach in vitro, whereby active
recombinant kinase is added directly to E. coli proteomic lysate
(followed by the same enrichment and MS/MS steps described).
In this way, recombinant kinases may be expressed, purified,
and activated in any appropriate system, while still realizing the
benefits of the low background phosphorylation levels in the E.
coli proteome.
We also wish to note that while compiling this manuscript we
became aware of work by the Huber lab at the University of
Illinois demonstrating the use of bacterial phosphorylation to
Figure 4. Receiver Operating Characteristic (ROC) curves for the scan-x and Scansite PKA and CK II kinase specific predictors. These
curves illustrate the tradeoff between sensitivity and specificity achieved by the ProPeL based scan-x (red) and combinatorial peptide library based
Scansite (blue) predictors, and indicate the similarity of results achieved using these experimentally orthogonal approaches. Panels (A) and (B) are
based on PKA serine and threonine predictions, respectively, while panels (C) and (D) are based on CK II serine and threonine predictions,
respectively. The Scansite web server does not score all phosphorylatable residues in a given sequence, which results in partial ROC curves.
doi:10.1371/journal.pone.0052747.g004
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(RLKs). Their successful results (simultaneously under review at
the time of this manuscript’s submission) further suggest that the
methodology is broadly applicable and can be used to query the
specificity of kinases from a wide range of species – the
overwhelming majority of which remain yet unknown.
Even in this post-genomic era, elucidation of cellular interac-
tions remains a significant bottleneck for our understanding of
molecular mechanisms in humans and other species. ProPeL can
rapidly decode the sequence-based determinants of kinase
specificity and provide experimentalists with the first line of
hypothesis generation necessary to fully annotate the breadth of
kinase-substrate interactions. In turn, we can better understand the
role of protein phosphorylation and how it affects cell physiology
in health and disease.
Methods
ProPeL PKA Methods
Plasmids, strains and in vivo proteome
phosphorylation. Human his-tagged full-length PRKACA/
pBEV construct was provided by Vertex Pharmaceuticals Inc
[26]. Escherichia coli OverExpress C41(DE3) cells from Lucigen
were transformed and plated on Luria-Bertani (LB) plates
supplemented with 50 mg/mL carbenicillin, with an untrans-
formed control. Colonies were inoculated in LB broth supple-
mented with 50 mg/mL carbenicillin and grown up overnight at
37uC with shaking at 200 rpm. Overnight cultures were diluted 10
fold into fresh media and grown under the same conditions until
OD600 reached 1, at which point protein expression was induced
with 1 mM Isopropyl-b-D-1-thiogalactopyranoside (IPTG) and
grown overnight. Cultures were centrifuged at 3000 g for 20
minutes and cell pellets were stored at 280uC until lysis.
Lysis and analysis of in vivo phosphorylation. Cell lysate
was prepared according to Ville ´n and Gygi [11] with minor
modifications. Cell pellets from 50 mL cultures were resuspended
in 3.3 mL lysis buffer (8M urea, 75 mM NaCl, 60 mM Tris,
pH 8.2) supplemented with 2 Complete Mini protease inhibitor
tablets (Roche) per 10 mL and Phosphatase Inhibitor Cocktail 1
(Calbiochem). Cells were lysed by sonication using 4630 second
pulses at 100 Watts (Sonic Dismembrator 60, Fisher Scientific),
with rest on ice between pulses. Crude lysate was clarified by
centrifugation at 20000 g and 4uC for 10 minutes. Protein
concentrations were determined by Bradford Protein Assay (Bio-
Rad) and phosphorylation level was evaluated by SDS-PAGE with
Pro-Q Diamond Phosphoprotein stain (Life Technologies), with
total protein evaluated by GelCode Blue staining (Pierce). Lysates
were stored at 280uC until further processing.
Protein digestion and phosphopeptide
enrichment. Phosphopeptide enrichment was performed ac-
cording to Ville ´n and Gygi. Fifteen mg of each protein sample was
reduced, alkylated and digested with trypsin. Peptides were
desalted with 500 mg 3 cc tC18 SepPak Vac solid-phase
extraction cartridges (Waters) and dried in a SpeedVac. Samples
were fractionated by HPLC using a Resource S column (GE
Healthcare) with 8 fractions collected according to Macek et al.
[27], dried in a SpeedVac to remove acetonitrile, and desalted
using 100 mg 1 cc SepPaks (Waters). Phosphopeptide enrichment
was performed with PhosSelect iron affinity gel (Sigma) and
desalted with StageTips made from C18 material (Proxeon), using
the combined IMAC/StageTip method detailed in Ville ´n and
Gygi. Samples were dried down by vacuum centrifugation and
stored at 220uC until mass spectrometry.
ProPeL CK II Methods
Plasmids, strains and In vivo proteome
phosphorylation. A plasmid containing the human CSNK2A1
gene in an Invitrogen Gateway donor vector (pDONR223) was
kindly provided by The Broad Institute and was transferred using
the standard Gateway protocol to the pDEST17 backbone for
bacterial expression (Life Technologies). Escherichia coli OverEx-
press C41(DE3) cells (Lucigen) were transformed and plated on
Luria-Bertani (LB) plates supplemented with 100 mg/mL ampicil-
lin, with the empty vector pUC19 (New England Biolabs) serving
as a control. Colonies were inoculated in LB broth supplemented
with 100 mg/mL ampicillin and grown up overnight at 37uC with
shaking at 250 rpm. Overnight cultures were diluted 50 fold into
fresh media and grown under the same conditions until OD600
reached 0.6–0.7, at which point protein expression was induced
with 1 mM Isopropyl-b-D-1-thiogalactopyranoside (IPTG) and
grown for a further 3 hours. Cultures were pelleted by
centrifugation at 3000 g and 4uC for 10 minutes. Pellets were
stored at 270uC until lysis.
Lysis and analysis of in vivo phosphorylation. Cell lysate
was prepared according to Ville ´n and Gygi [11] with minor
modifications. Cell pellets were resuspended in lysis buffer (8M
urea, 75 mM NaCl, 60 mM Tris, pH 8.2) supplemented with
Halt Protease Inhibitor Cocktail (EDTA-free) and Halt Phospha-
tase Inhibitor Cocktail (Pierce). Cells were lysed by sonication with
a Fisher Sonic Dismembrator F60 at 15% power using 15–20
second pulses, with 1 minute rest on ice between pulses, until lysate
was clear. Crude lysate was clarified by centrifugation at 2500 g
and 4uC for 10 minutes. Protein concentrations were determined
by Bichinchoninic Acid (BCA) Assay (Pierce) and phosphorylation
level was evaluated by SDS-PAGE with Pro-Q Diamond
Phosphoprotein stain (Life Technologies), with total protein
evaluated by GelCode Blue staining (Pierce). Lysates were stored
at 270uC until further processing.
Protein digestion and phosphopeptide
enrichment. Phosphopeptide enrichment was performed ac-
cording to Ville ´n and Gygi. Samples were reduced, alkylated and
digested with trypsin. Peptides were desalted with 500 mg 3 cc
tC18 SepPak Vac solid-phase extraction cartridges (Waters), snap-
frozen in liquid nitrogen and lyophilized. Samples were fraction-
ated by HPLC using a polySULFOETHYL A SCX column
(PolyLC) with 12 fractions collected, snap frozen in liquid
nitrogen, partially lyophilized to remove acetonitrile, and desalted
using 100 mg 1 cc SepPaks (Waters). Phosphopeptide enrichment
was performed with PhosSelect iron affinity gel (Sigma) and
desalted with StageTips made from C18 material (3M), as
described in Rappsilber et al. [28] using the combined IMAC/
StageTip method detailed in Ville ´n and Gygi. Samples were dried
down by vacuum centrifugation and stored at 220uC until mass
spectrometry.
Mass Spectrometry and Database Searching
For each of PKA and a negative control (untransformed cells), 8
SCX fractions were collected and enriched with IMAC as
described above.
For each of CK II and a negative control (pUC19 alone), 12
SCX fractions were collected and enriched with IMAC as
described above.
Before analysis with mass spectrometry, each fraction (either
from a set of 8 or a set of 12) was dried down and resuspended in
30 uL of loading Buffer A (see below). Fractions 5, 6, 7 and 8 for a
given starting sample were combined, dried and then resuspended
to 30 uL loading buffer. For the samples with 12 fractions,
fractions 9, 10, 11 and 12 were similarly combined before mass
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fractions), 4 uL was loaded (using buffer A) onto a C18
nanocapillary column with a pulled tip that sprayed directly into
the inlet of a Thermo Fisher Scientific LTQ Orbitrap XL mass
spectrometer.
Peptides were eluted from the column into the inlet of the mass
spectrometer using an Agilent 1200 HPLC binary pump with a
gradient that changed solvents from 100% to 65% Buffer A (0% to
35% Buffer B) over a 48 minute time period (Buffer A=3% ACN,
0.125% formic acid in water, and Buffer B=0.125% formic acid
in acetonitrile).
During the course of the injection, the mass spectrometer was
run using a TOP10 method (MS scan followed by Collision
Induced Dissociation MS/MS on the top 10 most intense MS
spectral peaks).
Each fraction’s spectra were searched using SEQUEST [29]
against the E. coli proteome which included decoy database entries
[30] and allowed for differential serine and threonine phosphate
modifications (+79.966331), a differential methionine oxidation
modification (15.9949146221) and a constant cysteine modifica-
tion of +57.02146374.
Following SEQUEST analysis, peptides from spectra containing
predicted serine and threonine phosphorylated peptides were
summarized for motif analysis. In order to minimize false positives,
for each of the two classes of peptide charges z=+2 and z=+3 and
greater, minimum XCORR thresholds were chosen to be above
the value of the highest XCORR for a decoy hit from the
database. The deltaXCORR (the difference between the first and
second hits to the databases) was always required to be 0.08. This
corresponded to a predicted False Discovery Rate (FDR) of 0%,
however it was still subject to statistical variations and may have
included some small contamination of false positives.
For each input sample, peptides from each fraction (or
combined fractions) were identified with a predicted FDR of 0%
as described, and then the peptides were combined into a single list
of non-redundant peptides for each fraction. Redundant peptides
occurring across fractions, but not across samples were highly
specific for a particular kinase, and many peptides were identified
in more than one independent spectrum. Negative controls
occasionally shared peptides with positive samples and with other
negative controls.
The final lists of peptides used for each kinases’ motif analysis
consisted of phosphopeptides that were not contained in controls
nor previously reported to be found in the normal E. coli proteome
[14].
pLogo/motif-x/scan-x Analyses
pLogo generation. pLogo images were generated using in-
house software. Specifically, pLogos depict residues proportional
to the log-odds of their binomial probabilities with respect to a
given background [13,31,32]. Here, the foreground data was
obtained by mapping phosphorylated tryptic peptides (identified
by MS/MS) back onto the E. coli proteome to retrieve necessary
adjacent sequence information and to create an aligned data set of
unique 15 mers centered on phosphorylation sites (using the same
procedure as in motif-x analyses). The E. coli background data set
was generated through alignment of all unique serine- or
threonine-centered 15 mers in the E. coli proteome. In a pLogo,
the most statistically significant residues appear closest to the x-
axis, with residues above the x-axis indicating overrepresentation
and those below the x-axis indicating underrepresentation. Fixed
positions within the pLogo (e.g., the central position) are depicted
on a grey background, and red horizontal lines denote the p,0.05
significance threshold (after Bonferroni correction). A detailed
manuscript describing pLogos as well as a pLogo generation web
site (http://plogo.uconn.edu) are currently in preparation.
motif-x analyses. motif-x analyses for both the PKA and CK
II MS/MS peptide identification results were carried out using an
internal version of the motif-x web tool [33] with the following
parameters selected: central residue=S* or T*, width=15,
foreground occurrence threshold=5, significance thresh-
old=0.00001, background database=NCBI E. coli proteome,
and background central residue=S or T.
scan-x analyses of known and random kinase
substrates. scan-x analyses of known and random substrates
were carried out using an internal version of the scan-x software
(described in detail in reference [13]). Known verified human
substrates of PKA and CK II were retrieved from the
PhosphoSitePlus database [16] (http://phosphosite.org), while
random substrates were obtained by randomly choosing an
equivalent number of serine/threonine 15 mers from the human
proteome. A whole proteome scan was also carried out using the
PKA and CK II pLogos against the entire SwissProt Human
proteome containing nearly 1.17 million serine- and threonine-
centered 15 mers to generate a ranked list of the highest scoring
predicted substrates for those respective kinases.
ROC curve analysis. To obtain a ‘‘gold-standard’’ data set
for ROC curve generation all human phosphorylation sites within
the PhosphoSitePlus database which were only known to be
phosphorylated by a single human kinase were retrieved. Sites
shown to be phosphorylated by PKA were called ‘‘positive PKA
sites’’ while those known to be phosphorylated by a different
kinase were called ‘‘negative PKA sites’’. Similarly, sites shown to
be phosphorylated by CK II were called ‘‘positive CK II sites’’
while all other kinase specific phosphorylation sites were called
‘‘negative CK II sites’’. scan-x analyses were carried out using an
internal version of the scan-x software (described in detail in
reference [13]. Scansite [18] analyses were carried out using the
Scansite 3.0 web server (http://scansite3.mit.edu) with either the
CK II or PKA matrices selected under minimum stringency
setting (to retrieve a maximal amount of scoring data). To plot the
ROC curves, sensitivity and specificity were calculated as
previously described [13]. Because Scansite does not provide
scoring results for every phosphorylatable residue provided in the
input, ROC curves could not be drawn completely to the upper
right hand corner (i.e., the point with 100% sensitivity and 100%
false positive rate).
Supporting Information
Table 1 Raw mass spectrometry phosphorylated pep-
tide sequence results for the Protein Kinase A (PKA),
Casein Kinase II (CK II), and control ProPeL experi-
ments.
(XLS)
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